Skip to main content
OpenTrials
Not yet recruiting

NCT Number: NCT07839091

Comparing Myopia Control Spectacle Lenses and Standard Single Vision Spectacle Lenses in Children With Myopia

The purpose of this clinical trial is to compare a new myopia control spectacle lens with a standard single vision spectacle lens in slowing the progression of myopia (nearsightedness) in healthy children aged 6 to under 11 years.

The main question being studied is:

Is the new myopia control spectacle lens more effective than a standard single vision spectacle lens in slowing myopia progression?

In this study, participants will wear a myopia control spectacle lens in one eye and a standard single vision spectacle lens in the other eye for the first 6 months. The lens assignment will then be switched between eyes for the remaining 6 months. Researchers will compare changes in eye axial length and refractive error between the two lens types.

Participants will:

* Wear the study spectacles for 12 months. * Attend scheduled follow-up visits at the Essilor R&D Centre, Singapore.

Not yet recruiting

Trial opening soon.

Get Notified

Key information

Age range

6 year–10 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Essilor R&D Centre Singapore

Singapore

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Volunteer participant with the willingness and ability to comply with all scheduled study visits.
  • Informed consent of parent/guardian and assent of participant.
  • Age equal to or greater than 6 years and less than 11 years (before 11th birthday) at the time of consent.
  • Spherical equivalent refraction (SER) equal or less than -0.50 D and equal or greater than -4.75D with astigmatism not more than 2.00 D.
  • Difference in SER (anisometropia) between two eyes should not exceed 1.00 D.
  • Best corrected Distance Visual Acuity (BCDVA) better than or equal to +0.10 LogMAR under high contrast in each eye.
  • Be in good general health, based on the participant and the parent's/guardian's knowledge.
  • Agree to wear the study spectacles for 12 hours per day and 7 days per week.
  • Agree not to be involved in other myopia control treatments.

Exclusion criteria

  • History of Atropine, Orthokeratology, Myopia Control Contact Lens, or Red Light treatment.
  • Strabismus by cover test at near or distance wearing correction.
  • History and presence of amblyopia.
  • Any ocular or systemic condition known to affect refractive status (e.g. keratoconus, diabetes, Downs syndrome, or other developmental disorders, etc.).
  • Current use of ocular or systemic medications which, in the investigator's opinion, may significantly affect pupil size, accommodation or refractive state.
  • History of ocular injury or surgery.
  • Participation in any clinical study within 30 days of the Baseline visit.
  • Current or anticipated use of growth hormones.
  • Study participants deemed inappropriate for the study by the investigator.
  • The inherent ocular/systemic discomfort (dry eyes, visual fatigue, headaches, etc.) that may affect the evaluation of the study lens wearing experience, from the investigator's perspective.

Treatment and study plan

Investigational Myopia Control Spectacle Lens

Device

A spectacle lens designed to help slow the progression of myopia in children

Single vision spectacle lens

Device

A standard spectacle lens used to correct refractive error without a specific myopia control feature

Primary outcomes

  1. Change in Eye Axial Length

    Time frame: From baseline to 6 months

Secondary outcomes

  1. Change in Eye Axial Length

    Time frame: From 6 months to 12 months

  2. Change in Eye Non-Cycloplegic Spherical Equivalent Refraction

    Time frame: From baseline to 6 months

  3. Change in Eye Non-Cycloplegic Spherical Equivalent Refraction

    Time frame: From 6 months to 12 months

Interested in participating?

Not yet recruiting

Trial opening soon.

Get Notified

Sponsors and collaborators

Lead sponsor

Essilor International

Industry

Registry information

Official study title

A Paired-Eye Comparison of Myopia Control Lenses in Myopic Children

Acronym: PEARL

Important dates

Study start
2026
Primary completion
2028
Study completion
2028
First posted
Sep 24, 2026
Registry last updated
Sep 24, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.